What are the responsibilities and job description for the VP, Regulatory Affairs San Francisco, CA/Hybrid position at BridgeBio Pharma?
Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our investigational product, acoramidis (AG10), is an orally administered small molecule designed to potently stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases.
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30 drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.
Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe.
The VP, Regulatory Affairs will provide strategic regulatory expertise to support the continued development and the commercialization of acoramidis for the proposed treatment of ATTR-CM and the prevention of ATTR. This role involves collaboration with cross-functional project teams in planning and execution of development strategies while providing leadership to global regulatory submissions. The VP, Regulatory Affairs will work in conjunction with various stakeholders across functional areas within the company and with external commercialization partners. The incumbent will be a key leader in the cardiorenal global regulatory team and will manage a highly skilled regulatory team based in the U.S. This role will serve as the primary point of contact for assigned regulatory agencies.
Responsibilities
- Serve as a critical regulatory team member with responsibility for regulatory strategies and execution of submissions for assigned projects
- Provide regulatory guidance and support for product development and registration strategies, including broad regulatory oversight for program development
- Ensure high-quality and timely regulatory submissions (IND / CTA / NDA / MAA, as applicable) in compliance with all applicable regulatory requirements and alignment with corporate goals
- Act as the primary liaison between the Company and assigned regulatory authorities
- Direct and assist internal staff and regulatory consultants, as required, to ensure compliance of the Company’s drug development activities with all U.S. and international requirements
- Perform all duties in keeping with the Company’s core values, policies, and all applicable regulations
- Great attention to detail; ability to organize, prioritize, and delegate
No matter your role at BridgeBio, successful team members are :
Education, Experience & Skills Requirements
What We Offer
Check below to see if you have what is needed for this opportunity, and if so, make an application asap.
J-18808-Ljbffr
Remote working / work at home options are available for this role.